Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Oct 31, 2017

Filed with the SEC on Dec 15, 2017 and accepted by EDGAR at Dec 15, 2017, 12:05 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-10-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2017-08-01 to 2017-10-31$1.1mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2017-05-01 to 2017-10-31$2.2mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2017-08-01 to 2017-10-31−$70.0kus-gaap:OperatingIncomeLoss
Operating income6 months2017-05-01 to 2017-10-31−$689.0kus-gaap:OperatingIncomeLoss
Income tax3 months2017-08-01 to 2017-10-31$11.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2017-05-01 to 2017-10-31$15.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-08-01 to 2017-10-31−$94.3kus-gaap:NetIncomeLoss
Net income6 months2017-05-01 to 2017-10-31−$768.5kus-gaap:NetIncomeLoss
Operating cash flow6 months2017-05-01 to 2017-10-31−$1.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2017-05-01 to 2017-10-31$942.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2017-10-31$660.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-10-31$3.5mus-gaap:AssetsCurrent
Total assetsAt period end2017-10-31$6.5mus-gaap:Assets
Current liabilitiesAt period end2017-10-31$5.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-10-31$6.1mus-gaap:Liabilities
Shareholders' equityAt period end2017-10-31$373.0kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-17-012357. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.